Site icon Impactiviti

Sanofi’s Acomplia / Zimulti rejected by FDA Panel

Developing story here.

As soon as I saw a few weeks ago that one of the concerns was suicidal thoughts, I figured that this drug approval was doomed. No way is the FDA going to go out on a limb with those risks…however small…for a weight-loss drug.

Exit mobile version